The Latest Breaking News from Disease

Tiny, engineered nanoparticles that can target specific immune cells may be a way to treat both cancer and cardiovascular disease.

A study of nearly 20,000 patients, suffering from a common lung disease called bronchiectasis, has found that the color of the phlegm or sputum can indicate the degree of inflammation in their lungs and predict their future results. The study has been presented at the European Respiratory Society International Congress…

More than 7,000 birds have died this year at five of the trust’s sites in England, Wales and Northern Ireland

Research shows humidity can kill viruses and help thwart infections.

A pet that has a zoonotic pathogen might not always look sick, and although the risk is low, it can pass those diseases on to us.

A common eye condition called glaucoma damages the optic nerve and subsequently the field of vision. Glaucoma can, in its most severe forms, result in blindness. Read further on Dynamite News

A recent national study published in The Journal of Hepatology has shed light on a concerning trend that close relatives of individuals with Metabolic-Associated Fatty Liver Disease (MASLD), formerly known as NAFLD, are at a significantly higher risk of developing liver cancer and experiencing advanced liver-related disorders. This study, conducted…

Rare diseases, often referred to as "orphan diseases," are those that affect a small portion of the population. Awareness and genomic technologies have increased interest in treatments, but costs remain prohibitive. Globally, 300 million people are affected by 7,000 rare diseases, with India having 70 million cases. Citizen initiatives, such…

Resistant starch is a nondigestible fibre that ferments in the large intestine and has previously been shown in animal studies to improve metabolism. Read further on Dynamite News:

At a recent medical gathering, researchers presented their latest hypotheses about what causes – and what could treat – the lingering disease.

Billions were sunk into the promise of treatments personalised to the individual. Now many believe the money might have been better spent on public health interventions